Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Src homologous and collagen (SHC) SH2-binding protein 1 (
SHCBP1
) is a member of the SHC family, and is overexpressed in numerous types of cancer. In addition, apoptosis serves an important role in the development of cancer. The purpose of this study was to examine the effect of
SHCBP1
on apoptosis and its potential underlying mechanism in lung cancer cells. Apoptosis was detected by flow cytometry and
caspase-3
activity analysis. The expression levels of
SHCBP1
and phosphatase and tensin homolog (PTEN) were detected by western blot analysis and reverse transcription-quantitative polymerase chain reaction. Cell viability was determined by MTT assay. The results indicated that
SHCBP1
was increased in lung cancer cell lines and lung cancer tissues compared with in normal lung cell lines and tissues. The apoptosis of lung cancer cells was significantly increased by
SHCBP1
small interfering RNA (siRNA), as indicated by the increased number of apoptotic cells and enhanced
caspase-3
activity. In addition, it was demonstrated that PTEN expression was modulated by
SHCBP1
knockdown; silencing of
SHCBP1
expression led to a significant increase in PTEN expression. Furthermore, inhibition of PTEN by siRNA reversed the increase in apoptosis induced by
SHCBP1
siRNA. These results suggested that
SHCBP1
may be upregulated in lung cancer and it may serve a key role in the apoptosis of lung cancer cells; this effect was associated with the expression of PTEN.
...
PMID:SHCBP1 regulates apoptosis in lung cancer cells through phosphatase and tensin homolog. 3142 58